BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11557032)

  • 1. Antisense inhibition of Chk2/hCds1 expression attenuates DNA damage-induced S and G2 checkpoints and enhances apoptotic activity in HEK-293 cells.
    Yu Q; Rose JH; Zhang H; Pommier Y
    FEBS Lett; 2001 Sep; 505(1):7-12. PubMed ID: 11557032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of human Cds1 (Chk2) kinase in DNA damage checkpoint and its regulation by p53.
    Tominaga K; Morisaki H; Kaneko Y; Fujimoto A; Tanaka T; Ohtsubo M; Hirai M; Okayama H; Ikeda K; Nakanishi M
    J Biol Chem; 1999 Oct; 274(44):31463-7. PubMed ID: 10531348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53.
    Chehab NH; Malikzay A; Appel M; Halazonetis TD
    Genes Dev; 2000 Feb; 14(3):278-88. PubMed ID: 10673500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chk2 is required for optimal mitotic delay in response to irradiation-induced DNA damage incurred in G2 phase.
    Rainey MD; Black EJ; Zachos G; Gillespie DA
    Oncogene; 2008 Feb; 27(7):896-906. PubMed ID: 17684483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TTK/hMps1 participates in the regulation of DNA damage checkpoint response by phosphorylating CHK2 on threonine 68.
    Wei JH; Chou YF; Ou YH; Yeh YH; Tyan SW; Sun TP; Shen CY; Shieh SY
    J Biol Chem; 2005 Mar; 280(9):7748-57. PubMed ID: 15618221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2.
    Yang S; Kuo C; Bisi JE; Kim MK
    Nat Cell Biol; 2002 Nov; 4(11):865-70. PubMed ID: 12402044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Drosophila chk2 gene loki is essential for embryonic DNA double-strand-break checkpoints induced in S phase or G2.
    Masrouha N; Yang L; Hijal S; Larochelle S; Suter B
    Genetics; 2003 Mar; 163(3):973-82. PubMed ID: 12663536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA damage-induced activation of p53 by the checkpoint kinase Chk2.
    Hirao A; Kong YY; Matsuoka S; Wakeham A; Ruland J; Yoshida H; Liu D; Elledge SJ; Mak TW
    Science; 2000 Mar; 287(5459):1824-7. PubMed ID: 10710310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 down-regulates CHK1 through p21 and the retinoblastoma protein.
    Gottifredi V; Karni-Schmidt O; Shieh SS; Prives C
    Mol Cell Biol; 2001 Feb; 21(4):1066-76. PubMed ID: 11158294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Chk2 tumor suppressor is not required for p53 responses in human cancer cells.
    Jallepalli PV; Lengauer C; Vogelstein B; Bunz F
    J Biol Chem; 2003 Jun; 278(23):20475-9. PubMed ID: 12654917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Checking in on Cds1 (Chk2): A checkpoint kinase and tumor suppressor.
    McGowan CH
    Bioessays; 2002 Jun; 24(6):502-11. PubMed ID: 12111733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.
    Shieh SY; Ahn J; Tamai K; Taya Y; Prives C
    Genes Dev; 2000 Feb; 14(3):289-300. PubMed ID: 10673501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of cytotoxicity of topoisomerase i poison by concurrent and sequential treatment with the checkpoint inhibitor UCN-01 involves disparate mechanisms resulting in either p53-independent clonogenic suppression or p53-dependent mitotic catastrophe.
    Tse AN; Schwartz GK
    Cancer Res; 2004 Sep; 64(18):6635-44. PubMed ID: 15374978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UCN-01 inhibits p53 up-regulation and abrogates gamma-radiation-induced G(2)-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1.
    Yu Q; La Rose J; Zhang H; Takemura H; Kohn KW; Pommier Y
    Cancer Res; 2002 Oct; 62(20):5743-8. PubMed ID: 12384533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chk1 is essential for tumor cell viability following activation of the replication checkpoint.
    Cho SH; Toouli CD; Fujii GH; Crain C; Parry D
    Cell Cycle; 2005 Jan; 4(1):131-9. PubMed ID: 15539958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topoisomerase inhibitor coralyne photosensitizes DNA, leading to elicitation of Chk2-dependent S-phase checkpoint and p53-independent apoptosis in cancer cells.
    Patro BS; Maity B; Chattopadhyay S
    Antioxid Redox Signal; 2010 Apr; 12(8):945-60. PubMed ID: 19922265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response.
    Jack MT; Woo RA; Hirao A; Cheung A; Mak TW; Lee PW
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9825-9. PubMed ID: 12097646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway.
    Chaturvedi P; Eng WK; Zhu Y; Mattern MR; Mishra R; Hurle MR; Zhang X; Annan RS; Lu Q; Faucette LF; Scott GF; Li X; Carr SA; Johnson RK; Winkler JD; Zhou BB
    Oncogene; 1999 Jul; 18(28):4047-54. PubMed ID: 10435585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irofulven induces replication-dependent CHK2 activation related to p53 status.
    Wang Y; Wiltshire T; Senft J; Reed E; Wang W
    Biochem Pharmacol; 2007 Feb; 73(4):469-80. PubMed ID: 17118344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.